Agios Pharmaceuticals | AGIO - Satış Brüt Kar





Satış Brüt Kar Değişiklik Tarih
AbbVie USD 12.54B 474M 2026-03
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
Amgen USD 6.89B 415M 2025-12
Arrowhead Research USD 256.47M 228.7M 2025-09
Astellas Pharma JPY 444.26B 12.55B 2026-03
AstraZeneca USD 12.61B 225M 2026-03
Bayer EUR 5.35B 1.02B 2025-09
Biogen USD 1.82B 169.5M 2026-03
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Exelixis USD 572.18M 7M 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
Incyte USD 1.17B 217.51M 2026-03
Ionis Pharmaceuticals USD 243M 48M 2026-03
Merck USD 10.85B 2.57B 2025-12
Moderna USD -566M 792M 2026-03
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Novartis USD 10.07B 184M 2026-03
Novartis USD 10.82B 694M 2025-09
Pfizer USD 12.28B 8.74B 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03